TRIM16 and melanoma: In melanoma, we have shown TRIM16 protein expression to be significantly associated with favourable prognosis in stage III melanoma patients, while enforced expression identified TRIM16 as a growth and metastasis suppressor, its effect mediated via IFNβ1 transcriptional activation [29].